Allmed Solutions Ltd
Allmed Solutions Ltd develops, manufactures, and markets minimally invasive products in various medical disciplines in Israel and internationally. The company offers medical devices for the treatment of type 2 diabetes in obese and overweight patients; and ProCatid system, a distal embolic protection system comprised of an independent filter unit that can be delivered, locked, and deployed on any… Read more
Allmed Solutions Ltd (ALMD) - Total Assets
Latest total assets as of June 2025: ILA37.56 Million ILA
Based on the latest financial reports, Allmed Solutions Ltd (ALMD) holds total assets worth ILA37.56 Million ILA as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Allmed Solutions Ltd - Total Assets Trend (2008–2024)
This chart illustrates how Allmed Solutions Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Allmed Solutions Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Allmed Solutions Ltd's total assets of ILA37.56 Million consist of 97.8% current assets and 2.2% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 8.7% |
| Accounts Receivable | ILA380.00K | 0.9% |
| Inventory | ILA0.00 | 0.0% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA9.00K | 0.0% |
| Goodwill | ILA0.00 | 0.0% |
Asset Composition Trend (2008–2024)
This chart illustrates how Allmed Solutions Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Allmed Solutions Ltd's current assets represent 97.8% of total assets in 2024, an increase from 90.5% in 2008.
- Cash Position: Cash and equivalents constituted 8.7% of total assets in 2024, down from 60.8% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2008.
- Asset Diversification: The largest asset category is accounts receivable at 0.9% of total assets.
Allmed Solutions Ltd Competitors by Total Assets
Key competitors of Allmed Solutions Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Allmed Solutions Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Allmed Solutions Ltd generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Allmed Solutions Ltd is currently not profitable relative to its asset base.
Allmed Solutions Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 15.09 | 19.17 | 6.95 |
| Quick Ratio | 15.09 | 19.17 | 6.68 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA34.32 Million | ILA 46.55 Million | ILA 35.75 Million |
Allmed Solutions Ltd - Advanced Valuation Insights
This section examines the relationship between Allmed Solutions Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.12 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -24.3% |
| Total Assets | ILA44.79 Million |
| Market Capitalization | $96.61K USD |
Valuation Analysis
Below Book Valuation: The market values Allmed Solutions Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Allmed Solutions Ltd's assets decreased by 24.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Allmed Solutions Ltd (2008–2024)
The table below shows the annual total assets of Allmed Solutions Ltd from 2008 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ILA44.79 Million | -24.29% |
| 2023-12-31 | ILA59.17 Million | +2.41% |
| 2022-12-31 | ILA57.77 Million | +5.44% |
| 2021-12-31 | ILA54.80 Million | -2.78% |
| 2020-12-31 | ILA56.36 Million | -16.14% |
| 2019-12-31 | ILA67.20 Million | +55.97% |
| 2018-12-31 | ILA43.09 Million | -16.90% |
| 2017-12-31 | ILA51.85 Million | -0.70% |
| 2016-12-31 | ILA52.22 Million | -8.31% |
| 2015-12-31 | ILA56.95 Million | +27.00% |
| 2014-12-31 | ILA44.85 Million | +2.85% |
| 2013-12-31 | ILA43.60 Million | -45.85% |
| 2012-12-31 | ILA80.52 Million | +1.22% |
| 2011-12-31 | ILA79.55 Million | +122.37% |
| 2010-12-31 | ILA35.78 Million | +211.66% |
| 2009-12-31 | ILA11.48 Million | -25.86% |
| 2008-12-31 | ILA15.48 Million | -- |